These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11154390)

  • 1. Management of calcium oxalate stones.
    Hanson KA
    Clin Excell Nurse Pract; 2001; 5(1):21-5. PubMed ID: 11154390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Randomized trials in the prevention of recurrent calcium oxalate stones].
    Presne C; Monge M; Bataille P; el Esper N; Choukroun G; Fournier A
    Nephrologie; 2003; 24(6):303-7. PubMed ID: 14584297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium oxalate kidney stones: another reason to encourage moderate calcium intakes and other dietary changes.
    Moyad MA
    Urol Nurs; 2003 Aug; 23(4):310-3. PubMed ID: 14552081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and medical management of the patient with calcium stone disease.
    Menon M; Krishnan CS
    Urol Clin North Am; 1983 Nov; 10(4):595-615. PubMed ID: 6636376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of diet in the prevention of common kidney stones.
    Krieg C
    Urol Nurs; 2005 Dec; 25(6):451-7. PubMed ID: 16438250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do thiazides prevent recurrent idiopathic renal calcium oxalate stones?
    Wolf H; Brocks P; Dahl C
    Proc Eur Dial Transplant Assoc; 1983; 20():477-80. PubMed ID: 6361755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of renal lithiasis.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and management of calcium stones.
    Park S; Pearle MS
    Urol Clin North Am; 2007 Aug; 34(3):323-34. PubMed ID: 17678983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic evidence of calculus attachment to Randall's plaque.
    Matlaga BR; Williams JC; Kim SC; Kuo RL; Evan AP; Bledsoe SB; Coe FL; Worcester EM; Munch LC; Lingeman JE
    J Urol; 2006 May; 175(5):1720-4; discussion 1724. PubMed ID: 16600740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
    Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metaphylaxis of recurrent renal calcium stones].
    Pasch A
    Ther Umsch; 2007 May; 64(5):253-8. PubMed ID: 17685083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
    Parks JH; Coe FL; Evan AP; Worcester EM
    BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones.
    Massey LK; Kynast-Gales SA
    J Am Diet Assoc; 2001 Mar; 101(3):326-31. PubMed ID: 11269613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.
    Mitwalli A; Ayiomamitis A; Grass L; Oreopoulos DG
    Int Urol Nephrol; 1988; 20(4):353-9. PubMed ID: 3170105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Randall's plaques in the pathogenesis of calcium stones.
    Matlaga BR; Coe FL; Evan AP; Lingeman JE
    J Urol; 2007 Jan; 177(1):31-8. PubMed ID: 17161996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.